ADIAL PHARMACEUTICALS, INC.
ADILDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How ADIL's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AD04 (ondansetron) | Phase 3 | Alcohol Use Disorder | - | - |
Frequently asked questions
What is in ADIAL PHARMACEUTICALS, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in ADIAL PHARMACEUTICALS, INC.'s (ADIL) pipeline across Phase 3. Its lead program is AD04 (ondansetron) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ADIAL PHARMACEUTICALS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ADIAL PHARMACEUTICALS, INC. (ADIL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ADIL biotech catalysts?→
Add ADIL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ADIAL PHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.